Product description
| Symbol | Cusip | Name | Amount | Value | Title Of Class | Pay of profile | |
|---|---|---|---|---|---|---|---|
| 45258J102 | 45258J102 | Immunovant Inc | 38000.0 | 1600940.0 | CORP | Long | |
| 925050106 | 925050106 | Verona Pharma Plc | 56000.0 | 1113280.0 | CORP | Long | |
| 03237H101 | 03237H101 | Amylyx Pharmaceuticals Inc | 151000.0 | 2222720.0 | CORP | Long | |
| 088786108 | 088786108 | Bicycle Therapeutics PLC | 90000.0 | 1627200.0 | CORP | Long | |
| 48576U106 | 48576U106 | Karyopharm Therapeutics Inc | 1125000.0 | 973125.0 | CORP | Long | |
| 24344T101 | 24344T101 | Deciphera Pharmaceuticals Inc | 112500.0 | 1814625.0 | CORP | Long | |
| 48576A100 | 48576A100 | Karuna Therapeutics Inc | 3500.0 | 1107785.0 | CORP | Long | |
| 15678U128 | 15678U128 | Cerevel Therapeutics Holdings Inc | 25000.0 | 1060000.0 | CORP | Long | |
| G7709Q104 | G7709Q104 | Royalty Pharma PLC | 40000.0 | 1123600.0 | CORP | Long | |
| 37733W204 | 37733W204 | GSK plc | 35000.0 | 1297100.0 | CORP | Long | |
| 31846V328 | 31846V328 | First American Funds Inc. | 11786584.25 | 11786584.25 | RF | Long | |
| 004225108 | 004225108 | Acadia Pharmaceuticals Inc | 26000.0 | 814060.0 | CORP | Long | |
| 761330109 | 761330109 | Revance Therapeutics Inc | 220000.0 | 1933800.0 | CORP | Long | |
| 86366E106 | 86366E106 | Structure Therapeutics Inc | 30000.0 | 1222800.0 | CORP | Long | |
| N/A | N/A | AMRYT PHARMA, PLC. | 300000.0 | 0.0 | CORP | Long | |
| G5960L103 | G5960L103 | Medtronic PLC | 20500.0 | 1688790.0 | CORP | Long | |
| 413197104 | 413197104 | Harmony Biosciences Holdings Inc | 122000.0 | 3940600.0 | CORP | Long | |
| 375558103 | 375558103 | Gilead Sciences, Inc. | 8500.0 | 688585.0 | CORP | Long | |
| 29082K105 | 29082K105 | Embecta Corp. | 200000.0 | 3786000.0 | CORP | Long | |
| 92337C203 | 92337C203 | Verastem Inc | 150000.0 | 1221000.0 | CORP | Long | |
| 04016X101 | 04016X101 | Argenx SE | 7750.0 | 2948332.5 | CORP | Long | |
| N/A | N/A | AMRYT PHARMA, PLC. | 300000.0 | 0.0 | CORP | Long | |
| 92941V308 | 92941V308 | VYNE Therapeutics Inc | 668151.0 | 1556791.83 | CORP | Long | |
| 91307C102 | 91307C102 | United Therapeutics Corporation | 18000.0 | 3958020.0 | CORP | Long | |
| 23257D103 | 23257D103 | CymaBay Therapeutics Inc. | 10000.0 | 236200.0 | CORP | Long | |
| G76279101 | G76279101 | Roivant Sciences Ltd | 55000.0 | 617650.0 | CORP | Long | |
| N90064101 | N90064101 | Uniqure N.V. | 421025.0 | 2850339.25 | CORP | Long | |
| 05156V102 | 05156V102 | Aurinia Pharmaceuticals Inc | 50000.0 | 449500.0 | CORP | Long | |
| 19249H103 | 19249H103 | Coherus Biosciences Inc | 1000000.0 | 3330000.0 | CORP | Long | |
| 604749101 | 604749101 | Mirum Pharmaceuticals Inc. | 50000.0 | 1476000.0 | CORP | Long | |
| 46333X108 | 46333X108 | Ironwood Pharmaceuticals, Inc. | 245000.0 | 2802800.0 | CORP | Long | |
| 45332Y109 | 45332Y109 | Inari Medical Inc | 5000.0 | 324600.0 | CORP | Long | |
| 695127100 | 695127100 | Pacira Biosciences Inc | 117500.0 | 3964450.0 | CORP | Long | |
| 67080N101 | 67080N101 | Nuvation Bio Inc | 450000.0 | 679500.0 | CORP | Long | |
| 74366E102 | 74366E102 | Protagonist Therapeutics Inc | 30000.0 | 687900.0 | CORP | Long | |
| 92332V107 | 92332V107 | Ventyx Biosciences Inc. | 10000.0 | 24700.0 | CORP | Long | |
| 92025Y103 | 92025Y103 | Valneva SE | 34298.0 | 352926.42 | CORP | Long | |
| 45253H101 | 45253H101 | ImmunoGen, Inc. | 127500.0 | 3780375.0 | CORP | Long | |
| 09061G101 | 09061G101 | Biomarin Pharmaceutical Inc. | 14000.0 | 1349880.0 | CORP | Long | |
| M96088105 | M96088105 | Urogen Pharma Ltd | 155000.0 | 2325000.0 | CORP | Long | |
| 717081103 | 717081103 | Pfizer Inc. | 80000.0 | 2303200.0 | CORP | Long | |
| 256086109 | 256086109 | Docgo Inc | 310000.0 | 1732900.0 | CORP | Long | |
| 268158201 | 268158201 | Dynavax Technologies Corp. | 100000.0 | 1398000.0 | CORP | Long | |
| 00370M103 | 00370M103 | Abivax SA | 267500.0 | 2862250.0 | CORP | Long | |
| 07725L102 | 07725L102 | BeiGene Ltd. | 7500.0 | 1352700.0 | CORP | Long | |
| 316175108 | 316175108 | Fidelity Institutional Cash Portfolios | 1.37 | 1.37 | RF | Long | |
| 771195104 | 771195104 | Roche Holdings, Ltd. | 16000.0 | 579680.0 | CORP | Long | |
| 36315X101 | 36315X101 | Galapagos NV | 105000.0 | 4268250.0 | CORP | Long | |
| 483497103 | 483497103 | KalVista Pharmaceuticals Inc. | 137000.0 | 1678250.0 | CORP | Long | |
| 92556V106 | 92556V106 | Viatris Inc | 35000.0 | 379050.0 | CORP | Long | |
| 09058V103 | 09058V103 | BioCryst Pharmaceuticals Inc. | 675000.0 | 4043250.0 | CORP | Long | |
| 931427108 | 931427108 | Walgreens Boots Alliance, Inc. | 120000.0 | 3133200.0 | CORP | Long | |
| 03152W109 | 03152W109 | Amicus Therapeutics Inc. | 140000.0 | 1986600.0 | CORP | Long | |
| G50871105 | G50871105 | Jazz Pharmaceuticals PLC | 10500.0 | 1291500.0 | CORP | Long | |
| 46116X101 | 46116X101 | Intra-Cellular Therapies Inc | 20000.0 | 1432400.0 | CORP | Long |